Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Novavax Inc (NVAX)    
$4.17 0.14 (3.25%) as of 4:30 Wed 4/23


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 208,480,000 as of 12/25
Market Cap: 869.36(M)
Last Volume: 2,084,683 Avg Vol: 1,646,665
52 Week Range: $1.79 - $6.65
Level I Sector: Health Care
Level II Sector:   Drugs
Level III Sector:      Biotechnology

Member Indexes:

    NASDAQ BIOTECHNOLOGY       NASDAQ COMPOSITE  
    NASDAQ NNM COMPOSITE  

Rankings:

     
Insider 3 Months    : 13.8
Insider 6 Months    : 13.8
Insider 3/6 Months : 26.8
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
 

Company Profile   Novavax is a clinical-stage biopharmaceutical company focused on developing recombinant vaccines to address a range of infectious diseases. Co.'s technology platform is based on proprietary recombinant vaccine technology that includes virus-like particles and recombinant protein micelle vaccines. Co.'s product pipeline targets a range of infectious diseases and its vaccine candidates are in or have completed clinical trials that target seasonal influenza, pandemic influenza, and respiratory syncytial virus. Further, CPL Biologics Private Limited, Co.'s joint venture company in India, is developing a rabies vaccine candidate.

 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 130,154 130,154 353,154 508,154
Total Buy Value $484,414 $484,414 $908,734 $1,185,384
Total People Bought 7 7 7 7
Total Buy Transactions 9 9 16 19
Total Shares Sold 6,044,000 6,044,000 6,123,000 6,123,000
Total Sell Value $29,922,701 $29,922,701 $30,116,241 $30,116,241
Total People Sold 5 5 6 6
Total Sell Transactions 9 9 10 10
End Date 2014-01-23 2013-10-22 2013-04-23 2012-04-23

   
Records found: 145
  Page 1 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Erck Stanley C CEO and President   •       •      –    2014-03-25 4/A B $4.27 $42,698 D/D 10,000 84,868 2.81     -
   Phillips Barclay A SVP, Chief Financial Officer   •       –      –    2014-03-25 4/A B $4.25 $21,225 D/D 5,000 14,868 2.74     -
   Young James F Director   –       •      –    2014-03-25 4 B $4.47 $111,837 D/D 25,000 425,000 2.39 -7%     
   Douglas Richard Director   –       •      –    2014-03-25 4 B $4.33 $216,700 D/D 50,000 250,000 2.39 -7%     
   Phillips Barclay A SVP, Chief Financial Officer   •       –      –    2014-03-25 4 S $4.25 $21,225 D/D (5,000) 14,868 7%     
   Erck Stanley C CEO and President   •       •      –    2014-03-25 4 S $4.27 $42,698 D/D (10,000) 84,868 7%     
   Satellite Overseas (holdings) Ltd 10% Owner   –       –       •   2014-03-21 4 S $4.69 $4,690,000 I/I (1,000,000) 9,500,000 -1%     
   Modi Rajiv I. Director   –       •      –    2014-03-21 4 S $4.69 $4,690,000 I/I (1,000,000) 9,500,000 -1%     
   Modi Rajiv I. Director   –       •      –    2014-03-20 4 S $4.99 $4,990,000 I/I (1,000,000) 10,500,000 16%     
   Satellite Overseas (holdings) Ltd 10% Owner   –       –       •   2014-03-20 4 S $4.99 $4,990,000 I/I (1,000,000) 10,500,000 16%     
   Modi Rajiv I. Director   –       •      –    2014-03-19 4 S $5.17 $5,170,000 I/I (1,000,000) 11,500,000 19%     
   Satellite Overseas (holdings) Ltd 10% Owner   –       –       •   2014-03-19 4 S $5.17 $5,170,000 I/I (1,000,000) 11,500,000 19%     
   Glenn Gregory M SVP, Research and Development   •       –      –    2014-03-14 4 S $5.48 $158,778 D/D (29,000) 4,102 22%     
   Glenn Gregory M SVP, Research and Development   •       –      –    2014-03-14 4 GD $0.00 $0 D/D 2,000 33,102     -
   Phillips Barclay A SVP, Chief Financial Officer   •       –      –    2014-01-31 4 B $2.29 $22,598 D/D 9,868 9,868 2.74 -23%     
   Hahn Timothy Jon SVP, Manufacturing & PD   •       –      –    2014-01-31 4 B $2.29 $21,563 D/D 9,416 80,416 2.74 -23%     
   Wilson Russell P SVP, Business Development   •       –      –    2014-01-31 4 B $2.29 $11,221 D/D 4,900 54,900 2.74 -23%     
   Glenn Gregory M SVP, Research and Development   •       –      –    2014-01-31 4 B $2.29 $9,394 D/D 4,102 31,000 2.74 -23%     
   Erck Stanley C President and CEO   •       •      –    2014-01-31 4 B $2.29 $27,178 D/D 11,868 74,868 2.81 -23%     
   Phillips Barclay A SVP, Chief Financial Officer   •       –      –    2013-06-12 4/A B $0.00 $0 D/D 0 0 2.66     -
   Phillips Barclay A Director   –       •      –    2013-06-12 4 B $1.90 $95,000 D/D 50,000 200,000 2.39 59%     
   Douglas Richard Director   –       •      –    2013-06-12 4 B $1.90 $95,000 D/D 50,000 200,000 2.39 59%     
   Hahn Timothy Jon SVP, Manufacturing & PD   •       –      –    2013-06-10 4 B $1.88 $39,480 D/D 21,000 71,000 2.74 60%     
   Glenn Gregory M Chief Scientific Officer   •       –      –    2013-06-07 4 B $1.83 $1,830 D/D 1,000 31,000 2.66 65%     
   Glenn Gregory M Chief Scientific Officer   •       –      –    2013-06-06 4 B $2.01 $2,010 D/D 1,000 30,000 2.66 47%     

  145 Records found
  1  2  3  4  5  6   
  Page 1 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed